Samo Guzelj & Žiga Jakopin. (2022). Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer Cells. Frontiers Media S.A..
Chicago Style (17th ed.) CitationSamo Guzelj and Žiga Jakopin. Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer Cells. Frontiers Media S.A., 2022.
MLA (9th ed.) CitationSamo Guzelj and Žiga Jakopin. Nucleotide-Binding Oligomerization Domain 1/Toll-Like Receptor 4 Co-Engagement Promotes Non-Specific Immune Response Against K562 Cancer Cells. Frontiers Media S.A., 2022.
Warning: These citations may not always be 100% accurate.